The hypoglycaemic sulphonylurea gliquidone was found, by conformation analysis, to display a U-shaped configuration, with hydrophobic cycles placed at the extremity of each branch and a peptidic bond placed at the bottom of the U. This configuration is similar to that recently observed with the hypoglycaemic sulphonylureas glimepiride and glibenclamide and non-sulphonylurea hypoglycaemic agents of the meglitinide family, such as S3075, repaglinide, A-4166 and KAD-1229. The identification of a conformation common to these various hypoglycaemic drugs may provide an imprint of their binding site at the level of the B-cell sulphonylurea receptor
Protein tyrosine phosphatase 1B (PTP 1B), a cytosolic PTP involved in down-regulation of receptor ty...
The preferred conformation of gangliosides GM3, GM2, GM1, GD1a and GD1b have been studied by computi...
Diabetes Mellitus is a chronic disease represented with high glucose blood levels. Although sulfonyl...
Non-sulfonylurea hypoglycemic agents of the meglitinide family such as S3075, repaglinide, KAD-1229,...
In pursuit of the working model of how glucagon interacts with the glucagon receptor and how glucago...
The molecular structure of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionic a...
Hypoglycemic sulfonylureas (e.g., gliclazide) are able to transport calcium across hydrophobic domai...
Crystal structures of three compounds, 2-4, of the title series with a range of hvpogiycemic activit...
The study of conformation in drug action can be approached from two directions, (i) that of the drug...
Repaglinide and nateglinide represent a new class of insulin secretagogues, structurally unrelated t...
The mechanism of action of sulphonylureas is not completely understood. In the present study we eval...
Several glucagon analogues containing substitutions in the N-terminal region, in particular residues...
It is reported the bioavailability analysis for ten secondary metabolites with hypoglycemic activity...
A series of somatostatin analogues with varying activities have been studied by 1H NMR in CD3OH at l...
Current information on pancreatic islet sulfonylurea receptors has been obtained with laboratory ani...
Protein tyrosine phosphatase 1B (PTP 1B), a cytosolic PTP involved in down-regulation of receptor ty...
The preferred conformation of gangliosides GM3, GM2, GM1, GD1a and GD1b have been studied by computi...
Diabetes Mellitus is a chronic disease represented with high glucose blood levels. Although sulfonyl...
Non-sulfonylurea hypoglycemic agents of the meglitinide family such as S3075, repaglinide, KAD-1229,...
In pursuit of the working model of how glucagon interacts with the glucagon receptor and how glucago...
The molecular structure of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionic a...
Hypoglycemic sulfonylureas (e.g., gliclazide) are able to transport calcium across hydrophobic domai...
Crystal structures of three compounds, 2-4, of the title series with a range of hvpogiycemic activit...
The study of conformation in drug action can be approached from two directions, (i) that of the drug...
Repaglinide and nateglinide represent a new class of insulin secretagogues, structurally unrelated t...
The mechanism of action of sulphonylureas is not completely understood. In the present study we eval...
Several glucagon analogues containing substitutions in the N-terminal region, in particular residues...
It is reported the bioavailability analysis for ten secondary metabolites with hypoglycemic activity...
A series of somatostatin analogues with varying activities have been studied by 1H NMR in CD3OH at l...
Current information on pancreatic islet sulfonylurea receptors has been obtained with laboratory ani...
Protein tyrosine phosphatase 1B (PTP 1B), a cytosolic PTP involved in down-regulation of receptor ty...
The preferred conformation of gangliosides GM3, GM2, GM1, GD1a and GD1b have been studied by computi...
Diabetes Mellitus is a chronic disease represented with high glucose blood levels. Although sulfonyl...